If rescheduled, cannabis would allow for tax break opportunities that cannabis businesses cannot currently access.

A bipartisan bill was recently introduced to the House to end the consideration of prior or current cannabis use when assigning security clearance for federal employment. 

Cocannco may have an opportunity to become a publicly traded company and target investment Clearly California is growing.

Clearly California is a Cocannco target investment based in central California. The company has developed a proven, profitable model and has begun scaling. Founded in 2020, Clearly California has plans to expand and reach $5.5 million in sales by 2024.

Cannabis businesses will have to quickly pivot when federal prohibition ends so they can comply with new laws and regulations. Understanding alcohol laws and regulations is a good way for businesses to prepare for this.

23 states have legalized adult-use cannabis, 17 have legalized medical use, and only 10 prohibitive states remain.

In a newly published analysis by MJBiz, cannabis sales are projected to generate more than $100 billion in US economic impact in 2023. The impact is anticipated to increase by another 12.5% in 2024 and is projected to increase by 41% from 2023 to 2028. 

California has awarded nearly $20 million to 16 state universities to research many cannabis issues and compounds. These research matters include cannabis and mental health, delta-8, delta-10, and the first cannabis study on legacy genetics. 

After it failed to pass at the end of 2022, the Secure And Fair Enforcement (SAFE) Banking Act was reintroduced by bipartisan lawmakers in both chambers of Congress.

As we anticipate the revival of federal cannabis legalization as a vital issue in the 2024  presidential elections, the cannabis industry will continue to grow throughout legal states.

The FDA recently announced it is renewing its contract with Waterloo University to conduct a cannabis study. Since 2019, the FDA and the University have conducted International Cannabis Policy Study (ICPS).

The NBA is currently working on a groundbreaking agreement with its players that could allow players to also invest in and promote cannabis companies. 

Nonaccredited investors are well-positioned to fill the vacuum in the cannabis space, introducing a new Reg D offering open to nonaccredited investors, and the short-term investment opportunity in Clearly California is still available.

With the market downturn and predatory-like lending that cannabis businesses are now faced with in the search for capital, the opportunity opens for the public to replace private investors.

Missouri’s adult-use cannabis sales began on February 3 of this year. It’s expected to generate more than half a billion dollars in sales in the first year. In the first month of sales, Missouri made $103 million.

Thanks to New Frontier Data, we now have data that specifies just how good the next seven years will be for the US legal cannabis market.

Clearly California is a Cocannco target investment based in central California and already profitable. Founded in 2020, the company has plans to expand and reach $5.5 million in sales by 2024. 

Regulation A+ was signed into law as part of the JOBS Act in 2012. This Act means entrepreneurs have greater access to capital, and non-accredited investors have greater access to investing in high-growth companies. It is, in essence, crowdfunding. 

The “Marijuana 1-to-3 Act” directs the Drug Enforcement Administration (DEA) to make this change. Rep. Steube says the measure would allow “researchers to access federal funds to determine its medical value.”

According to a recent study published in the Psychological Medicine Journal, cannabis legalization has not led to an increase in substance use disorders or increased use of other illicit drugs, and “should not be considered a ‘gateway drug.’”